克洛沙作为PROTAC技术的E3联体
Reina Takano1,2, Nobumichi Ohoka3, Takashi Kurohara2
1Graduate School of Medical Life Science, Yokohama City University, Kanagawa 210-9501, Japan.
ACS medicinal chemistry letters
|February 19, 2025
概括
研究人员开发了使用克洛扎作为E3连接体的新型蛋白质分解向嵌合体 (PROTACs). 这种方法成功降解了标蛋白,包括与癌症相关的雌激素受体α,推动了药物发现.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 针对蛋白质分解的仿真体 (PROTACs) 是一种新兴的治疗方式.
- 新型无素酶 (E3) 配体的开发对于 PROTAC 技术至关重要.
- 识别新的E3配体扩大了可向蛋白质降解的范围.
研究的目的:
- 为了研究抗精神病药物克洛沙平作为一种新的E3配体,用于PROTAC开发.
- 为了合成和评估基于克洛扎的PROTACs用于蛋白质降解.
- 探索基于克洛扎的PROTACs在癌症治疗中的潜力.
主要方法:
- 基于克洛扎的PROTACs的合成,包括Halo-PEG-Clozapine和Tamoxifen-PEG-Clozapine.
- 基于细胞的测试来评估目标蛋白质 (HaloTag和雌激素受体α) 的降解.
- 利用抑制剂和小干扰RNAs (siRNAs) 来阐明降解途径.
主要成果:
- 一种克洛札PROTAC成功诱导了一种模型HaloTag融合蛋白质的降解.
- 塔莫西芬-PEG-Clozapine在MCF-7乳腺癌细胞中证明了雌激素受体α的降解.
- 经证实,雌激素受体α的降解通过涉及E3酶N-recognin5的泛素-蛋白酶系统发生.
结论:
- 克洛扎作为一个可行的和有前途的E3配体用于PROTAC设计.
- 克洛扎的使用扩大了创建新型PROTACs的分子工具包.
- 这项研究有助于推进药物发现,通过使向蛋白质降解成为疾病治疗的目标.
更多相关视频
相关概念视频
Psychosis: Goals of Pharmacotherapy
102
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
102
Antipsychotic Drugs: Typical and Atypical Agents
149
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
149
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K


